Stay updated on Zoetis Press Releases

Sign up to get notified when there's something new on the Zoetis Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Zoetis Press Releases page

  1. Check
    3 days ago
    Change Detected
    Summary
    Zoetis UK announces Lenivia® (izenivetmab injection) launch in Great Britain, a long-acting antibody therapy delivering up to three months of osteoarthritis pain relief for dogs. This update adds the product launch news and date to the press releases page.
    Difference
    0.7%
    Check dated 2026-10-01T15:52:56.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A new press release item appears announcing Zoetis will host a webcast and conference call on November 5, 2026 to review third quarter 2026 results, with CEO Kristin Peck and CFO/COO Jay Saccaro. It also includes access details, pre-registration information, and a replay link for the event.
    Difference
    0.8%
    Check dated 2026-09-24T19:32:39.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    A new investor-relations press release has been added announcing that Zoetis executives will participate in the Morgan Stanley 24th Annual Global Healthcare Conference on Sept 14, 2026, with a link to the live webcast and a post-event replay. The entry is titled 'Zoetis to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference' and is dated September 02, 2026.
    Difference
    0.8%
    Check dated 2026-09-03T18:46:30.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Adds a new press release entry about the FDA EUA for Simparica Trio to treat New World screwworm in dogs and puppies, illustrating expanded veterinary solutions and regulatory progress; accompanying navigation changes reconfigure access to site sections.
    Difference
    2%
    Check dated 2026-08-20T13:46:43.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    A new press release reports UK approval of Portela (relfovetmab injection), a long-acting NGF monoclonal antibody for feline osteoarthritis, approved for easing OA pain with a three-month dosing interval in Leatherhead, UK. This expands Zoetis’ portfolio in the UK market and updates the press releases page with the latest regulatory milestone.
    Difference
    0.9%
    Check dated 2026-08-06T09:40:50.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The page gains a new press release entry announcing Portela (relfovetmab) launch in Canada and the European Union, highlighting Portela as the first long-acting anti-NGF monoclonal antibody therapy for cats with up to three months of OA pain relief from a single injection. The entry is titled 'Zoetis Launches Portela® (relfovetmab) in Canada and the European Union' and dated July 22, 2026.
    Difference
    0.9%
    Check dated 2026-07-23T05:46:25.000Z thumbnail image

Stay in the know with updates to Zoetis Press Releases

Enter your email address, and we'll notify you when there's something new on the Zoetis Press Releases page.